How convenient that current Q cash spend brings this mob just above the "please answer funding q's" of below 2Q of cash.
Management can't be trusted.
- Forums
- ASX - By Stock
- PAR
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 0.225 |
7 | 211158 | 0.220 |
10 | 205052 | 0.215 |
12 | 169584 | 0.210 |
8 | 175200 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25000 | 1 |
0.235 | 42540 | 3 |
0.240 | 93500 | 3 |
0.245 | 1000 | 1 |
0.250 | 89857 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online